The Unfolded Protein Response: A Novel Insight into Chronic Kidney Disease (CKD)
Journal Title: Nephrology – Open Journal - Year 2017, Vol 3, Issue 1
Abstract
Chronic kidney disease (CKD) is a clinical syndrome, characterized by a progressive decline of renal function. CKD is associated with a wide range of metabolic abnormalities including hypertension, anemia, acidosis, and mineral bone diseases.1 The progression of CKD may lead to end-stage renal diseases. CKD affects nearly 500 million people worldwide and thus has become a global public health concern. While the pathogenesis of CKD remains poorly understood, accumulating studies have revealed that the endoplasmic reticulum (ER) stress contributes to the onset and progression of CKD including renal fibrosis, which can lead to end-stage renal disease, independent of the original cause of CKD.
Authors and Affiliations
Na Liu
Keywords
Related Articles
- EP ID EP558280
- DOI 10.17140/NPOJ-3-e008
- Views 129
- Downloads 0
Individualized Sodium Prescription in Hemodialysis: An Ally for Better Dialysis Outcomes?
The current practice in dialysis centres all over the world is to use standard sodium dialysate for all patients. Recently, there is a lot of interest in manipulating the dialysate sodium concentration to reduce fluid ov...
Variation of Peripheral Th17/Treg Imbalance in Patients with Idiopathic Membranous Nephropathy after Cyclosporin A Treatment: A Prognostic Marker of Idiopathic Membranous Nephropathy
Despite impressive improvements in the 1-year graft survival for kidney transplantation, which has risen from 60% to 95% over the last few decades, little progress has been made in long-term graft survival. Half of the g...
What we do and do not know About Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Woman’s Day
Chronic Kidney Disease affects approximately 10% of the world’s adult population: it is within the top 20 causes of death worldwide, and it’s impact on patients and their families can be devastating. World Kidney Day and...
Review of the REPRISE Trial: Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
In the past, Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and its Outcomes (TEMPO) trial showed Tolvaptan, a vasopressin V2-receptor antagonist, slowed the decline i...
Comparison of Hospital-Acquired and Community-Acquired Acute Kidney Injury in Hospitalized Patients
Introduction: Little is known about patients sustaining Acute Kidney Injury (AKI) in the Community Acquired Acute Kidney Injury (CA-AKI) and how this differs from AKI in Hospital Acquired Acute Kidney Injury (HA-AKI). Th...